Literature DB >> 11092237

Lack of evidence of an association between the carriage of virulence plasmid and the bacteremia of Salmonella typhimurium in humans.

C H Chiu1, C Chu, J T Ou.   

Abstract

The involvement of the virulence plasmid (pSTV) of Salmonella typhimurium in human salmonellosis was examined. Most of the 224 clinical strains isolated from the blood (53) and nonblood samples (171) contained a 90 kb or larger plasmid, most of which were pSTV. The rates of pSTV carriage in the isolates showed no statistically significant difference between those derived from the blood and those from other sources (87% vs. 83%; chi2=0.49, 0.1<P<0.9), suggesting that pSTV may not play a critical role in promoting S. typhimurium bacteremia in humans. Nine strains with representative plasmid profiles were tested for the mouse virulence. The result revealed that these clinical isolates contained all three virulent types known: the avirulent, the highly virulent when a pSTV was present, and the moderately virulent regardless of the presence or absence of pSTV. This indicated that mouse virulence of S. typhimurium did not correlate their virulence in humans. Clinical data showed that most patients with primary bacteremia had underlying immunosuppressive diseases, whereas only a few patients with secondary bacteremia had preexisting diseases (87% vs. 13%; chi2=22.73, P<0.005). It is suggested that the contribution of pSTV to S. typhimurium bacteremia in humans is likely to be limited, and both the host factor and the microbial virulence determinants on the chromosome are more important than virulence plasmid in predisposing patients to bacteremia.

Entities:  

Mesh:

Year:  2000        PMID: 11092237     DOI: 10.1111/j.1348-0421.2000.tb02558.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  7 in total

1.  Characterization of a laboratory-derived, high-level ampicillin-resistant Salmonella enterica serovar Typhimurium strain that caused meningitis in an infant.

Authors:  Cheng-Hsun Chiu; Chishih Chu; Lin-Hui Su; Wan-Yu Wu; Tsu-Lan Wu
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Large drug resistance virulence plasmids of clinical isolates of Salmonella enterica serovar Choleraesuis.

Authors:  C Chu; C H Chiu; W Y Wu; C H Chu; T P Liu; J T Ou
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

Review 3.  Salmonella pathogenicity and host adaptation in chicken-associated serovars.

Authors:  Steven L Foley; Timothy J Johnson; Steven C Ricke; Rajesh Nayak; Jessica Danzeisen
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

4.  In vivo acquisition of ceftriaxone resistance in Salmonella enterica serotype anatum.

Authors:  Lin-Hui Su; Cheng-Hsun Chiu; Chishih Chu; Mei-Hui Wang; Ju-Hsin Chia; Tsu-Lan Wu
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

5.  A multi-drug resistant Salmonella Typhimurium ST213 human-invasive strain (33676) containing the bla CMY-2 gene on an IncF plasmid is attenuated for virulence in BALB/c mice.

Authors:  Magdalena Wiesner; Juan J Calva; Víctor H Bustamante; Deyanira Pérez-Morales; Marcos Fernández-Mora; Edmundo Calva; Claudia Silva
Journal:  BMC Microbiol       Date:  2016-02-09       Impact factor: 3.605

6.  Characterization of Salmonella enterica isolates causing bacteremia in Lima, Peru, using multiple typing methods.

Authors:  Claudia Silva; Laura Betancor; Coralith García; Lizeth Astocondor; Noemí Hinostroza; Julieta Bisio; Javier Rivera; Lucía Perezgasga; Victoria Pérez Escanda; Lucía Yim; Jan Jacobs; Francisco García-Del Portillo; José A Chabalgoity; José L Puente
Journal:  PLoS One       Date:  2017-12-21       Impact factor: 3.240

7.  Association of virulence plasmid and antibiotic resistance determinants with chromosomal multilocus genotypes in Mexican Salmonella enterica serovar Typhimurium strains.

Authors:  Magdalena Wiesner; Mussaret B Zaidi; Edmundo Calva; Marcos Fernández-Mora; Juan J Calva; Claudia Silva
Journal:  BMC Microbiol       Date:  2009-07-03       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.